Tocqueville Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.23M Hold
151,700
0.02% 336
2025
Q1
$1.07M Hold
151,700
0.02% 335
2024
Q4
$1.13M Hold
151,700
0.02% 347
2024
Q3
$748K Hold
151,700
0.01% 371
2024
Q2
$778K Sell
151,700
-200,000
-57% -$1.03M 0.01% 359
2024
Q1
$1.87M Sell
351,700
-50,000
-12% -$266K 0.03% 278
2023
Q4
$2.49M Hold
401,700
0.05% 237
2023
Q3
$3.03M Sell
401,700
-50,000
-11% -$377K 0.06% 222
2023
Q2
$4.37M Sell
451,700
-93,500
-17% -$904K 0.08% 192
2023
Q1
$2.06M Sell
545,200
-13,300
-2% -$50.2K 0.04% 263
2022
Q4
$3.62M Sell
558,500
-44,400
-7% -$288K 0.07% 219
2022
Q3
$5.36M Sell
602,900
-5,550
-0.9% -$49.3K 0.11% 173
2022
Q2
$6.07M Buy
608,450
+115,000
+23% +$1.15M 0.11% 180
2022
Q1
$5.71M Buy
493,450
+71,500
+17% +$828K 0.09% 217
2021
Q4
$4.68M Buy
421,950
+131,850
+45% +$1.46M 0.06% 262
2021
Q3
$2.68M Buy
290,100
+40,000
+16% +$369K 0.04% 327
2021
Q2
$2.81M Buy
250,100
+94,300
+61% +$1.06M 0.04% 334
2021
Q1
$1.65M Buy
155,800
+32,900
+27% +$349K 0.03% 389
2020
Q4
$1.33M Hold
122,900
0.02% 399
2020
Q3
$1.2M Buy
122,900
+1,300
+1% +$12.6K 0.02% 377
2020
Q2
$968K Buy
121,600
+2,800
+2% +$22.3K 0.02% 394
2020
Q1
$1.03M Buy
118,800
+5,350
+5% +$46.5K 0.03% 351
2019
Q4
$1.28M Hold
113,450
0.02% 415
2019
Q3
$1.23M Hold
113,450
0.02% 435
2019
Q2
$1.06M Buy
+113,450
New +$1.06M 0.01% 474
2013
Q3
Sell
-18,474
Closed -$244K 936
2013
Q2
$244K Buy
+18,474
New +$244K ﹤0.01% 834